StudyGraphics #VisualAbstract Low-PV study: Adding ropeginterferon alfa-2b to phlebotomy and aspirin shows improvement in response rates for treatment of polycythaemia vera in low-risk patients February 12, 2021 | Kathleen Lau Facebook Twitter Pinterest WhatsApp Linkedin ReddIt Email Print RELATED ARTICLESMORE FROM AUTHOR #VisualAbstract: Tislelizumab plus chemotherapy improves outcomes for advanced squamous non small cell lung cancer over chemotherapy alone #VisualAbstract Rituximab plus high-dose chemotherapy (MegaCHOEP) show similar long-term efficacy to conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma #VisualAbstract: Local excision margins greater than 1 cm and receipt of radiotherapy are associated with improved overall survival in Merkel cell carcinoma
